← Mechanisms of action
ANGPTL3
SINGLE PROTEINHomo sapiens
Preferred name: Angiopoietin-related protein 3 ChEMBL ↗
Linked proteins
Drugs acting on this target (18)
| Active Pharmaceutical Ingredient | Mechanism Type ▲ | Approval Status | API Type | Mechanism of Action |
|---|---|---|---|---|
| evinacumab (EVKEEZA) | Antagonist | approved | mAb | ANGPTL3 |
| aln-ang3 | Antisense inhibitor | experimental | Nucleic acid | ANGPTL3 antisense inhibitor |
| edp167 | Antisense inhibitor | experimental | Nucleic acid | ANGPTL3 antisense inhibitor |
| js401 | Antisense inhibitor | experimental | Nucleic acid | ANGPTL3 antisense inhibitor |
| syh2070 | Antisense inhibitor | experimental | Nucleic acid | ANGPTL3 antisense inhibitor |
| akcea-angptl3-lrx | Inhibitor | experimental | Nucleic acid | ANGPTL3 inhibitor |
| aro-ang3 | Inhibitor | experimental | Nucleic acid | ANGPTL3 inhibitor |
| evinacumab (EVKEEZA) | Inhibitor | approved | mAb | ANGPTL3 inhibitor |
| ionis angptl3-lrx | Inhibitor | experimental | Nucleic acid | ANGPTL3 inhibitor |
| ly3434172 | Inhibitor | experimental | mAb | ANGPTL3 inhibitor |
| ly3475766 | Inhibitor | experimental | mAb | ANGPTL3 inhibitor |
| ly3561774 | Inhibitor | experimental | Nucleic acid | ANGPTL3 inhibitor |
| shr-1918 | Inhibitor | experimental | Small molecule | ANGPTL3 inhibitor |
| verve-201 | Inhibitor | experimental | Nucleic acid | ANGPTL3 inhibitor |
| vsa003 | Modulator | experimental | Small molecule | ANGPTL3 modulator |
| ang003 | Supplementation | experimental | Recombinant protein | ANGPTL3 supplementation |
| ctx310 | Supplementation | experimental | Gene therapy | ANGPTL3 supplementation |
| lna043 | Supplementation | experimental | Recombinant protein | ANGPTL3 supplementation |